Kyntra Bio, Inc. logo

Kyntra Bio, Inc. (KYNB)

Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
7. 95
+0.17
+2.1851%
After Hours
$
8. 19
+0.24 +3.0189%
31.49M Market Cap
- P/E Ratio
- Div Yield
27,511 Volume
-2.67 Eps
$ 7.78
Previous Close
Add Transaction
Day Range
7.8 8.05
Year Range
6.32 12.6
Want to track KYNB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Kyntra Bio, Inc. (KYNB) Statistics

Valuation metrics

Market Cap 31.49M
Enterprise value -18.18M
Trailing P/E (ttm) 0.14
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 7.03
Price/Book (mrq) -1.08
Enterprise Value/Revenue -3.94
Enterprise Value/EBITDA 0.19

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 23.3K
Average volume (90 days) 27.25K

Price summary

52-Week low 6.32
52-Week high 12.6
Beta -
50-Day moving average 7.35
200-Day moving average 7.17

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 17 Jun 2025

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 39.68%
Operating margin -11.01%

Operational effectiveness

Return on assets 1.81%
Return on equity -6.06%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 1.14
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 45.25
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 22.56
Total debt (mrq) -
Total Debt/Equity (mrq) -0.44
Current ratio (mrq) 2.69%
Book value per share (mrq) -2.01

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -